on NANOBIOTIX (EPA:NANO)
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Paris, France; Cambridge, Massachusetts (USA); May 23, 2024 - NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX), a late-clinical stage biotechnology company focusing on physics-based cancer treatments, announced that its management will participate in a fireside chat at the Jefferies Global Healthcare Conference.
The conference will take place on Wednesday, June 5, 2024, at 5:00 PM EDT / 11:00 PM CEST in New York, NY. Bart Van Rhijn, the chief financial officer of Nanobiotix, will represent the company.
The discussion will be webcast live on the Investors section of the Company’s website, and a replay will be available following the event.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news